Annexon Financial Ratios
NASDAQ: ANNXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.02+0.02 (+0.50%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Annexon ratio analysis
Return on equity reached -97.7%, meaning Annexon generated -0.98 dollars of profit for every dollar of shareholders' equity. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Annexon financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Price / book | 3.44 | 2.54 | 1.37 | 1.22 | 1.90 | 1.23 | — |
| Return on equity (ROE) | -97.7% | -47.2% | -53.6% | -61.4% | -56.2% | -18.4% | — |
| Return on assets (ROA) | -74.5% | -39.5% | -45.1% | -49.8% | -45.4% | -17.8% | -74.5% |
| Current ratio | 5.68 | 10.37 | 14.72 | 11.10 | 11.39 | 33.33 | 9.21 |